Risk-directed treatment intensification significantly reduces the risk of relapse among children and adolescents with acute lymphoblastic leukemia and intrachromosomal amplification of chromosome 21: a comparison of the MRC ALL97/99 and UKALL2003 trials. (2013)

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1200/JCO.2013.48.9377

PubMed Identifier: 23940220

Publication URI: http://europepmc.org/abstract/MED/23940220

Type: Journal Article/Review

Volume: 31

Parent Publication: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Issue: 27

ISSN: 0732-183X